Ignite Creation Date:
2024-07-17 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06492850
Status:
RECRUITING
Last Update Posted:
2024-07-09
First Post:
2024-07-01
Brief Title:
Gene Therapy for RPGR Gene Mutation-associated X-linked Retinitis Pigmentosa
Sponsor:
Frontera Therapeutics
Organization:
Frontera Therapeutics
Organization Data
Organization:
Frontera Therapeutics
Class:
INDUSTRY
Study ID:
FT002-C101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Frontera Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None